Time-dependent interactions of the hypotensive effects of sildenafil citrate and sublingual glyceryl trinitrate

被引:13
作者
Oliver, James J. [1 ]
Kerr, Debra M. [1 ]
Webb, David J. [1 ]
机构
[1] Queens Med Res Inst, Clin Pharmacol Unit, Edinburgh EH16 4TJ, Midlothian, Scotland
关键词
blood pressure; glyceryl trinitrate; hypotension; phosphodiesterase type 5 inhibition; sildenafil citrate; VIAGRA;
D O I
10.1111/j.1365-2125.2009.03375.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT center dot Co-administration of inhibitors of phosphodiesterase type 5 with organic nitrates can cause profound hypotension. center dot For this reason, it is recommended that sildenafil and organic nitrates are not administered within 24 h of one another. center dot However, the time course of the interaction between sildenafil and sublingual glyceryl trinitrate (GTN) has not previously been investigated. WHAT THIS STUDY ADDS center dot In men with angina there is an interaction between oral sildenafil and sublingual GTN for >= 8 h, but from 6 h this interaction is not more than additive. center dot These data may be helpful to clinicians who are considering the use of GTN in patients presenting with angina who have received sildenafil within 24 h. To investigate the time course of the hypotensive interaction between sildenafil and glyceryl trinitrate (GTN). Two double-blind, placebo-controlled, randomized, crossover studies were performed. Subjects were challenged with sublingual GTN 400 mu g at different times after oral sildenafil 100 mg. After each GTN challenge frequent measures of blood pressure (BP) were made. In the first study GTN was given 1-48 h after sildenafil/placebo to 33 healthy men. In the second study GTN was given 1-8 h after sildenafil/placebo to 20 men with stable angina. In healthy men there was a greater mean maximum reduction in BP with sildenafil/GTN than with placebo/GTN only at 1 h. In angina patients, there was a greater mean maximum reduction in BP with sildenafil/GTN than with placebo/GTN for up to 8 h. The mean (95% confidence interval) differences in maximum systolic BP reduction (mmHg) at 1, 4, 6 and 8 h were -16 (-12, -21), -12 (-4, -20), -6 (1, -12) and -9 (-3, -15), all P < 0.05 except at 6 h (NS). At 6 and 8 h the interaction was not more than additive, and hypotensive symptoms did not occur. In men with angina there is an interaction on BP reduction between sildenafil and GTN for >= 8 h after sildenafil administration, but this is no more than additive from 6 h. These data may be helpful to clinicians who are considering the use of GTN in patients presenting with angina who have received sildenafil within 24 h.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 14 条
[1]   Phosphodiesterase type 5 inhibitors for erectile dysfunction [J].
Carson, CC ;
Lue, TF .
BJU INTERNATIONAL, 2005, 96 (03) :257-280
[2]   Sources of variability in blood pressure measurement using the Dinamap PRO 100 automated oscillometric device [J].
Chang, JJ ;
Rabinowitz, D ;
Shea, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (12) :1218-1226
[3]   Use of sildenafil (Viagra) in patients with cardiovascular disease [J].
Cheitlin, MD ;
Hutter, AM ;
Brindis, RG ;
Ganz, P ;
Kaul, S ;
Russell, RO ;
Zusman, RM ;
Forrester, JS ;
Douglas, PS ;
Faxon, DP ;
Fisher, JD ;
Gibbons, RJ ;
Halperin, JL ;
Hochman, JS ;
Kaul, S ;
Weintraub, WS ;
Winters, WL ;
Wolk, MJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (01) :273-282
[4]  
Hofmann F, 2000, J CELL SCI, V113, P1671
[5]  
MUIRHEAD GJ, 2002, BR J CLIN PHARM S1, V53, P37
[6]  
O'Brien, 1996, Blood Press Monit, V1, P55
[7]   Effect of regular phosphodiesterase type 5 inhibition in hypertension [J].
Oliver, James J. ;
Melville, Vanessa P. ;
Webb, David J. .
HYPERTENSION, 2006, 48 (04) :622-627
[8]   Nitrate therapy for stable angina pectoris [J].
Parker, JD ;
Parker, JO .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (08) :520-531
[9]   Cyclic GMP phosphodiesterases and regulation of smooth muscle function [J].
Rybalkin, SD ;
Yan, C ;
Bornfeldt, KE ;
Beavo, JA .
CIRCULATION RESEARCH, 2003, 93 (04) :280-291
[10]   HEME STOICHIOMETRY OF HETERODIMERIC SOLUBLE GUANYLATE-CYCLASE [J].
STONE, JR ;
MARLETTA, MA .
BIOCHEMISTRY, 1995, 34 (45) :14668-14674